SART3
Basic information
Region (hg38): 12:108522214-108561400
Links
Phenotypes
GenCC
Source:
- disseminated superficial actinic porokeratosis (Moderate), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Porokeratosis, disseminated superficial actinic, 1 | AD | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Dermatologic | 15840095 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SART3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 3 | |||||
missense | 58 | 61 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 1 | |||||
Total | 0 | 0 | 58 | 3 | 4 |
Variants in SART3
This is a list of pathogenic ClinVar variants found in the SART3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
12-108523519-C-T | not specified | Uncertain significance (Jan 07, 2025) | ||
12-108523521-G-A | not specified | Uncertain significance (May 31, 2024) | ||
12-108523525-C-T | not specified | Likely benign (Jan 16, 2024) | ||
12-108523527-G-T | not specified | Uncertain significance (May 24, 2024) | ||
12-108523531-C-G | not specified | Uncertain significance (Aug 14, 2023) | ||
12-108523548-G-A | not specified | Uncertain significance (May 02, 2024) | ||
12-108523553-G-A | Benign (Dec 31, 2019) | |||
12-108523563-T-C | not specified | Uncertain significance (Jul 09, 2021) | ||
12-108523569-G-C | not specified | Uncertain significance (Feb 08, 2025) | ||
12-108523632-C-T | not specified | Uncertain significance (Feb 05, 2024) | ||
12-108524323-A-G | not specified | Uncertain significance (Jun 05, 2023) | ||
12-108524434-T-C | not specified | Uncertain significance (Jul 02, 2024) | ||
12-108524443-C-T | not specified | Uncertain significance (Dec 07, 2024) | ||
12-108524466-G-A | not specified | Uncertain significance (Jul 30, 2024) | ||
12-108524481-T-C | not specified | Uncertain significance (Dec 28, 2023) | ||
12-108525473-C-T | Intellectual disability, Neurodevelopmental defects and Developmental delay with 46,XY gonadal dysgenesis | Likely pathogenic (Mar 06, 2023) | ||
12-108525476-T-C | not specified | Uncertain significance (Feb 28, 2024) | ||
12-108525545-C-T | not specified | Uncertain significance (Jun 10, 2022) | ||
12-108525561-C-T | not specified | Uncertain significance (May 08, 2024) | ||
12-108525604-G-C | not specified | Uncertain significance (Jun 27, 2022) | ||
12-108526104-A-G | not specified | Uncertain significance (Nov 09, 2024) | ||
12-108526170-G-A | Intellectual disability, Neurodevelopmental defects and Developmental delay with 46,XY gonadal dysgenesis | Likely pathogenic (Mar 06, 2023) | ||
12-108526187-T-C | not specified | Uncertain significance (Oct 16, 2023) | ||
12-108526257-T-C | not specified | Uncertain significance (Oct 26, 2022) | ||
12-108526316-G-A | Intellectual disability, Neurodevelopmental defects and Developmental delay with 46,XY gonadal dysgenesis | Likely pathogenic (Mar 06, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SART3 | protein_coding | protein_coding | ENST00000228284 | 19 | 38820 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.997 | 0.00339 | 125720 | 0 | 28 | 125748 | 0.000111 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.806 | 498 | 551 | 0.903 | 0.0000335 | 6335 |
Missense in Polyphen | 132 | 194.36 | 0.67915 | 2148 | ||
Synonymous | 0.208 | 208 | 212 | 0.982 | 0.0000136 | 1788 |
Loss of Function | 5.85 | 9 | 56.4 | 0.159 | 0.00000324 | 635 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000271 | 0.000271 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.000139 | 0.000139 |
European (Non-Finnish) | 0.000141 | 0.000141 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000653 | 0.0000653 |
Other | 0.000164 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: U6 snRNP-binding protein that functions as a recycling factor of the splicing machinery. Promotes the initial reassembly of U4 and U6 snRNPs following their ejection from the spliceosome during its maturation (PubMed:12032085). Also binds U6atac snRNPs and may function as a recycling factor for U4atac/U6atac spliceosomal snRNP, an initial step in the assembly of U12-type spliceosomal complex. The U12-type spliceosomal complex plays a role in the splicing of introns with non-canonical splice sites (PubMed:14749385). May also function as a substrate-targeting factor for deubiquitinases like USP4 and USP15. Recruits USP4 to ubiquitinated PRPF3 within the U4/U5/U6 tri-snRNP complex, promoting PRPF3 deubiquitination and thereby regulating the spliceosome U4/U5/U6 tri-snRNP spliceosomal complex disassembly (PubMed:20595234). May also recruit the deubiquitinase USP15 to histone H2B and mediate histone deubiquitination, thereby regulating gene expression and/or DNA repair (PubMed:24526689). May play a role in hematopoiesis probably through transcription regulation of specific genes including MYC (By similarity). {ECO:0000250|UniProtKB:Q9JLI8, ECO:0000269|PubMed:12032085, ECO:0000269|PubMed:14749385, ECO:0000269|PubMed:20595234, ECO:0000269|PubMed:24526689}.;
Recessive Scores
- pRec
- 0.151
Intolerance Scores
- loftool
- 0.607
- rvis_EVS
- -1.04
- rvis_percentile_EVS
- 7.84
Haploinsufficiency Scores
- pHI
- 0.0816
- hipred
- Y
- hipred_score
- 0.704
- ghis
- 0.666
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.992
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Sart3
- Phenotype
- hematopoietic system phenotype;
Zebrafish Information Network
- Gene name
- sart3
- Affected structure
- pharyngeal arch
- Phenotype tag
- abnormal
- Phenotype quality
- malformed
Gene ontology
- Biological process
- spliceosomal tri-snRNP complex assembly;regulation of alternative mRNA splicing, via spliceosome;spliceosomal snRNP assembly;mRNA splicing, via spliceosome;cell morphogenesis;nucleosome assembly;RNA splicing;regulation of gene expression;homeostasis of number of cells;hematopoietic stem cell proliferation;positive regulation of histone deubiquitination
- Cellular component
- nucleus;nucleoplasm;U6atac snRNP;cytoplasm;Cajal body;nuclear speck;U4/U6 x U5 tri-snRNP complex;ASAP complex;U4/U6 snRNP;U4atac/U6atac snRNP
- Molecular function
- RNA binding;protein binding;U6 snRNA binding;U4 snRNA binding;U6atac snRNA binding;histone binding;ubiquitin-specific protease binding